QQQ   359.61 (+0.47%)
AAPL   176.08 (+0.74%)
MSFT   317.54 (+0.17%)
META   300.83 (+0.59%)
GOOGL   131.11 (+0.66%)
AMZN   131.27 (+1.67%)
TSLA   246.99 (+0.86%)
NVDA   422.22 (+1.47%)
NIO   8.34 (-2.23%)
BABA   87.20 (-1.25%)
AMD   97.38 (+1.23%)
T   15.06 (-0.40%)
F   12.59 (+1.29%)
MU   68.58 (-0.44%)
CGC   0.94 (+11.86%)
GE   111.70 (+0.40%)
DIS   81.01 (-0.30%)
AMC   8.15 (+6.82%)
PFE   32.98 (+0.89%)
PYPL   58.86 (+1.69%)
NFLX   384.80 (+1.31%)
QQQ   359.61 (+0.47%)
AAPL   176.08 (+0.74%)
MSFT   317.54 (+0.17%)
META   300.83 (+0.59%)
GOOGL   131.11 (+0.66%)
AMZN   131.27 (+1.67%)
TSLA   246.99 (+0.86%)
NVDA   422.22 (+1.47%)
NIO   8.34 (-2.23%)
BABA   87.20 (-1.25%)
AMD   97.38 (+1.23%)
T   15.06 (-0.40%)
F   12.59 (+1.29%)
MU   68.58 (-0.44%)
CGC   0.94 (+11.86%)
GE   111.70 (+0.40%)
DIS   81.01 (-0.30%)
AMC   8.15 (+6.82%)
PFE   32.98 (+0.89%)
PYPL   58.86 (+1.69%)
NFLX   384.80 (+1.31%)
QQQ   359.61 (+0.47%)
AAPL   176.08 (+0.74%)
MSFT   317.54 (+0.17%)
META   300.83 (+0.59%)
GOOGL   131.11 (+0.66%)
AMZN   131.27 (+1.67%)
TSLA   246.99 (+0.86%)
NVDA   422.22 (+1.47%)
NIO   8.34 (-2.23%)
BABA   87.20 (-1.25%)
AMD   97.38 (+1.23%)
T   15.06 (-0.40%)
F   12.59 (+1.29%)
MU   68.58 (-0.44%)
CGC   0.94 (+11.86%)
GE   111.70 (+0.40%)
DIS   81.01 (-0.30%)
AMC   8.15 (+6.82%)
PFE   32.98 (+0.89%)
PYPL   58.86 (+1.69%)
NFLX   384.80 (+1.31%)
QQQ   359.61 (+0.47%)
AAPL   176.08 (+0.74%)
MSFT   317.54 (+0.17%)
META   300.83 (+0.59%)
GOOGL   131.11 (+0.66%)
AMZN   131.27 (+1.67%)
TSLA   246.99 (+0.86%)
NVDA   422.22 (+1.47%)
NIO   8.34 (-2.23%)
BABA   87.20 (-1.25%)
AMD   97.38 (+1.23%)
T   15.06 (-0.40%)
F   12.59 (+1.29%)
MU   68.58 (-0.44%)
CGC   0.94 (+11.86%)
GE   111.70 (+0.40%)
DIS   81.01 (-0.30%)
AMC   8.15 (+6.82%)
PFE   32.98 (+0.89%)
PYPL   58.86 (+1.69%)
NFLX   384.80 (+1.31%)
NASDAQ:VRTX

Vertex Pharmaceuticals (VRTX) Earnings Date, Estimates & Call Transcripts

$350.67
+1.14 (+0.33%)
(As of 09/25/2023 ET)
Compare
Today's Range
$344.62
▼
$350.80
50-Day Range
$340.48
▼
$362.46
52-Week Range
$276.57
▼
$367.00
Volume
698,146 shs
Average Volume
1.17 million shs
Market Capitalization
$90.51 billion
P/E Ratio
27.08
Dividend Yield
N/A
Price Target
$367.04
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability

Earnings Summary

Upcoming
Earnings Date
Oct. 26Estimated
Actual EPS
(Aug. 1)
$3.53 Beat By $0.06
Consensus EPS
(Aug. 1)
$3.47
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

VRTX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

VRTX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Vertex Pharmaceuticals Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20235$2.18$3.20$2.65 
Q2 20236$2.67$3.79$3.34 
Q3 20236$2.77$3.81$3.43 
Q4 20236$2.84$3.82$3.30 
FY 202323$10.46$14.62$12.71 
Q1 20241$3.50$3.50$3.50 
Q2 20241$3.43$3.43$3.43 
Q3 20241$3.38$3.38$3.38 
Q4 20241$3.37$3.37$3.37 
FY 20244$13.68$13.68$13.68 
Q1 20251$3.52$3.52$3.52 

VRTX Earnings Date and Information

Vertex Pharmaceuticals last announced its earnings data on August 1st, 2023. The pharmaceutical company reported $3.53 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.47 by $0.06. The firm earned $2.49 billion during the quarter, compared to analyst estimates of $2.41 billion. Vertex Pharmaceuticals has generated $12.95 earnings per share over the last year ($12.95 diluted earnings per share) and currently has a price-to-earnings ratio of 27.1. Earnings for Vertex Pharmaceuticals are expected to grow by 11.31% in the coming year, from $13.26 to $14.76 per share. Vertex Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, October 26th, 2023 based off prior year's report dates.

Vertex Pharmaceuticals Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
10/26/2023
Estimated)		------- 
8/1/2023Q2 2023$3.47$3.53+$0.06$3.54$2.41 billion$2.49 billion
5/1/2023Q1 2023$2.51$3.05+$0.54$2.65$2.34 billion$2.37 billion    
2/7/2023Q4 2022$3.11$3.76+$0.65$3.51$2.30 billion$2.30 billion    
10/27/2022Q3 2022$3.31$3.62+$0.31$3.65$2.23 billion$2.33 billion
8/4/2022Q2 2022$3.05$3.25+$0.20$3.37$2.13 billion$2.20 billion      
5/5/2022Q1 2022$3.17$3.16($0.01)$3.36$2.07 billion$2.10 billion      
1/26/2022Q4 2021$2.91$3.18+$0.27$3.36$1.99 billion$2.07 billion    
11/2/2021Q3 2021$2.74$3.56+$0.82$3.22$1.85 billion$1.98 billion    
7/29/2021Q2 2021$2.25$3.11+$0.86$5.34$1.71 billion$1.79 billion    
4/29/2021Q1 2021$2.38$2.98+$0.60$2.59$1.66 billion$1.72 billion  
1/31/2021Q4 2020$2.59$2.51($0.08)$2.14$1.58 billion$1.63 billion  
10/29/2020Q3 2020$1.96$2.64+$0.68$2.19$1.48 billion$1.54 billion    












Vertex Pharmaceuticals Earnings - Frequently Asked Questions

When is Vertex Pharmaceuticals's earnings date?

Vertex Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, October 26th, 2023 based off last year's report dates. Learn more on VRTX's earnings history.

Did Vertex Pharmaceuticals beat their earnings estimates last quarter?

In the previous quarter, Vertex Pharmaceuticals (NASDAQ:VRTX) reported $3.53 earnings per share (EPS) to beat the analysts' consensus estimate of $3.47 by $0.06. Learn more on analysts' earnings estimate vs. VRTX's actual earnings.

How much revenue does Vertex Pharmaceuticals generate each year?

Vertex Pharmaceuticals (NASDAQ:VRTX) has a recorded annual revenue of $9.51 billion.

How much profit does Vertex Pharmaceuticals generate each year?

Vertex Pharmaceuticals (NASDAQ:VRTX) has a recorded net income of $3.32 billion. VRTX has generated $12.95 earnings per share over the last four quarters.

What is Vertex Pharmaceuticals's price-to-earnings ratio?

Vertex Pharmaceuticals (NASDAQ:VRTX) has a trailing price-to-earnings ratio of 27.08 and a forward price-to-earnings ratio of 26.45. The price/earnings-to-growth ratio is 2.58.

What is Vertex Pharmaceuticals's EPS forecast for next year?

Vertex Pharmaceuticals's earnings are expected to grow from $13.26 per share to $14.76 per share in the next year, which is a 11.31% increase.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:VRTX) was last updated on 9/25/2023 by MarketBeat.com Staff

My Account -